ArticleJournal of clinical immunology2026
Inborn Errors of Immunity Genotype: A Retrospective Study from the United Arab Emirates.
Article in Journal of clinical immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inborn errors of immunity (IEI) contribute substantially to morbidity in the Middle East and North Africa (MENA), particularly in the United Arab Emirates (UAE), where high consanguinity increases the prevalence of autosomal-recessive and complex genetic disorders. Regional IEI genomic data remain limited, and population-specific variants are underrepresented in global databases, limiting diagnostic accuracy and precision-medicine implementation. We retrospectively reviewed 2,500 patients assigned immunodeficiency-related ICD codes over ten years at two tertiary centers in Al Ain, UAE. Based on the availability of genetic testing reports for inborn errors of immunity, 232 patients (~ 9%) were included in the analysis. Variants were annotated using American College of Medical Genetics and Genomics guidelines and open-access resources, including Ensembl and ClinVar, and genes were classified according to the International Union of Immunological Societies framework. Allele frequencies were reported based on gnomAD and the Emirati Genome Project. Reported variants were systematically reclassified using Franklin, VarSome, ClinGen, and HGMD, where available. Based on original reports, 245 IEI-related variant observations were identified across 107 genes: 99 (40.4%) pathogenic/likely pathogenic, 68 (27.8%) benign/likely benign, and 78 (31.8%) variants of uncertain significance (VUS). Following reclassification, pathogenic/likely pathogenic variants increased to 107 (43.7%), VUS decreased to 54 (22.0%), and benign/likely benign variants increased to 76 (31.0%). Recurrent genes included ATM, DOCK8, RAG1, RAG2, UNC13D, LRBA, MEFV, and NLRP3, and 7.8% of patients carried multiple IEI-related variants. This study provides one of the largest genomic characterizations of IEI in the UAE and demonstrates that systematic variant reinterpretation improves diagnostic accuracy, underscoring the importance of population-specific genomic resources for precision medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.